One week after pharmaceutical billionaire Phillip Frost was accused by the Securities and Exchange Commission of participating in a “pump-and-dump” scheme, the 81-year-old Opko Health CEO has released a statement denying the allegations against him.
The Chicago-based company raised $110 million in its Series E financing and plans to use its funds to extend its focus beyond oncology treatment, and into cardiovascular diseases and diabetes.
Primary care provider One Medical announced Wednesday that it had received an investment of up to $350 million from private equity firm The Carlyle Group.
VC incubator Accelerator Life Sciences launched its latest biotech startup Monday with a $30 million Series A investment from the likes of Pfizer, Eli Lilly and AbbVie.